Nifty
:
24252.00
Sensex
:
77540.83
20.15 (0.08%)
3.11 (0.00%)
Nifty
Sensex
:
:
24252.00
77540.83
20.15 (0.08%)
3.11 (0.00%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
69/99

BSE: 532305 | NSE: INDSWFTLAB

NSE BSE
329.59
21-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  335.17
  •  337.6
  •  325.21
  •  333.51
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  366668
  •  120791348.29
  •  351.3
  •  87.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,864.08
  • 50.55
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,454.52
  • N/A
  • 1.94

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.93%
  • 7.12%
  • 34.45%
  • FII
  • DII
  • Others
  • 10.7%
  • 0.00%
  • 4.80%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.50
  • -8.82
  • -22.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 73.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.16
  • 3.68
  • 3.51

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.82
  • 0.86
  • 0.84

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.43
  • 5.65
  • 5.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
191.45
158.32
20.93%
169.79
142.37
19.26%
150.85
128.80
17.12%
152.64
148.30
2.93%
Expenses
158.02
149.13
5.96%
149.22
146.79
1.66%
146.68
135.45
8.29%
151.17
145.37
3.99%
EBITDA
33.43
9.19
263.76%
20.57
-4.42
-
4.18
-6.65
-
1.47
2.94
-50.00%
EBIDTM
17.46%
5.80%
12.11%
-3.11%
2.77%
-5.16%
0.97%
1.98%
Other Income
7.65
8.99
-14.91%
2.22
-0.31
-
27.58
16.64
65.75%
17.86
17.22
3.72%
Interest
0.71
1.15
-38.26%
-2.44
-26.76
-
0.67
10.03
-93.32%
2.01
9.94
-79.78%
Depreciation
7.58
6.68
13.47%
8.12
7.44
9.14%
8.83
5.81
51.98%
6.98
5.61
24.42%
PBT
32.56
10.35
214.59%
11.96
230.46
-94.81%
16.39
-6.58
-
10.34
4.70
120.00%
Tax
7.99
1.71
367.25%
-3.15
8.19
-
6.87
-1.08
-
2.30
0.18
1,177.78%
PAT
24.57
8.65
184.05%
15.11
222.27
-93.20%
9.52
-5.50
-
8.04
4.51
78.27%
PATM
12.83%
5.46%
8.90%
156.13%
6.31%
-4.27%
5.27%
3.04%
EPS
2.84
1.28
121.88%
1.74
32.33
-94.62%
1.17
-0.93
-
0.98
0.67
46.27%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
664.73
561.71
1,280.90
1,207.31
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
Net Sales Growth
15.05%
-56.15%
6.10%
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
 
Cost Of Goods Sold
287.69
287.95
661.46
655.59
537.43
451.44
396.66
403.36
390.56
392.19
353.01
Gross Profit
377.04
273.76
619.44
551.73
501.30
439.90
382.98
353.24
371.96
305.24
300.23
GP Margin
56.72%
48.74%
48.36%
45.70%
48.26%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
Total Expenditure
605.09
581.10
1,026.69
978.11
843.11
708.54
636.16
630.48
628.43
591.47
545.97
Power & Fuel Cost
-
13.72
61.43
76.07
58.45
37.31
34.65
37.44
29.58
26.00
22.65
% Of Sales
-
2.44%
4.80%
6.30%
5.63%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
Employee Cost
-
105.85
141.52
126.17
117.40
97.86
95.92
90.98
88.12
69.65
62.76
% Of Sales
-
18.84%
11.05%
10.45%
11.30%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
Manufacturing Exp.
-
36.88
45.50
43.41
40.85
64.24
59.30
50.06
63.50
43.40
38.56
% Of Sales
-
6.57%
3.55%
3.60%
3.93%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
General & Admin Exp.
-
74.24
55.12
38.17
36.03
27.17
27.58
27.27
28.69
23.33
21.54
% Of Sales
-
13.22%
4.30%
3.16%
3.47%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
Selling & Distn. Exp.
-
60.81
38.68
37.29
39.03
28.74
21.65
21.30
27.92
29.06
28.87
% Of Sales
-
10.83%
3.02%
3.09%
3.76%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
Miscellaneous Exp.
-
1.65
22.98
1.42
13.93
1.77
0.40
0.07
0.06
7.86
28.87
% Of Sales
-
0.29%
1.79%
0.12%
1.34%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
EBITDA
59.65
-19.39
254.21
229.20
195.62
182.80
143.48
126.12
134.09
105.95
107.28
EBITDA Margin
8.97%
-3.45%
19.85%
18.98%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
Other Income
55.31
81.38
45.37
33.50
43.50
22.71
33.46
36.91
25.82
22.62
15.91
Interest
0.95
2.92
51.10
92.17
95.55
100.22
106.65
92.24
35.38
90.27
106.42
Depreciation
31.51
24.48
53.30
57.36
131.04
87.29
90.06
104.05
86.62
88.26
84.75
PBT
71.25
34.59
195.17
113.17
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
Tax
14.01
7.27
160.31
38.69
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
Tax Rate
19.66%
2.82%
27.56%
44.72%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
PAT
57.24
250.53
421.45
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
PAT before Minority Interest
57.24
250.53
421.45
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.61%
44.60%
32.90%
3.96%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
PAT Growth
-75.11%
-40.56%
781.14%
-
-
-
-
31.71%
-
-
 
EPS
6.58
28.80
48.44
5.50
-0.25
-0.36
-2.44
3.33
2.53
-4.50
-6.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
1,173.00
931.46
681.93
600.97
603.51
640.64
587.81
553.24
531.32
517.43
Share Capital
68.74
59.09
59.81
59.81
59.81
59.81
48.29
46.00
45.46
41.68
Total Reserves
1,030.16
872.37
622.12
541.17
543.70
580.83
539.53
505.69
483.39
475.74
Non-Current Liabilities
0.15
-19.46
741.18
813.57
840.15
828.33
901.32
437.80
494.76
717.24
Secured Loans
6.38
11.16
752.60
847.78
884.13
885.96
953.86
503.97
563.69
666.84
Unsecured Loans
19.33
0.00
0.00
0.00
0.00
4.93
11.72
16.52
28.32
79.48
Long Term Provisions
11.37
1.23
17.79
17.03
15.73
14.76
14.34
13.32
9.16
0.00
Current Liabilities
220.58
221.28
371.09
334.47
314.52
323.07
356.00
935.93
1,005.02
950.81
Trade Payables
110.23
93.98
203.99
175.95
138.82
135.23
126.68
128.64
102.36
132.43
Other Current Liabilities
98.75
22.80
105.67
89.10
81.29
72.92
136.49
490.25
496.93
314.60
Short Term Borrowings
5.55
2.71
49.17
64.03
93.43
114.93
92.52
311.31
405.70
503.66
Short Term Provisions
6.04
101.79
12.25
5.39
0.98
0.00
0.31
5.73
0.03
0.12
Total Liabilities
1,393.70
1,133.26
1,794.20
1,748.90
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
Net Block
260.07
5.36
585.04
627.53
738.65
843.14
901.20
924.59
1,032.56
1,098.73
Gross Block
568.16
8.15
1,330.90
1,316.68
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
Accumulated Depreciation
308.09
2.79
745.86
689.15
563.38
516.18
477.75
424.68
374.28
321.78
Non Current Assets
528.35
472.13
629.68
673.56
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
Capital Work in Progress
10.68
0.00
7.71
10.31
18.84
11.45
19.87
68.60
70.26
78.47
Non Current Investment
174.09
110.54
30.34
29.06
35.53
17.45
31.03
31.02
31.09
17.63
Long Term Loans & Adv.
81.25
353.92
4.17
3.96
6.11
56.95
56.95
63.50
54.24
68.96
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
14.31
0.00
Current Assets
865.35
661.13
1,163.12
1,073.32
941.88
863.03
836.09
839.26
828.64
921.70
Current Investments
39.37
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
114.18
10.46
438.60
428.50
375.67
342.82
316.61
316.91
343.56
356.02
Sundry Debtors
164.52
169.12
505.32
454.78
432.39
396.45
350.85
407.76
357.27
372.45
Cash & Bank
428.04
431.93
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
Other Current Assets
119.25
0.00
9.02
16.92
122.23
113.18
138.66
105.14
111.69
170.66
Short Term Loans & Adv.
115.31
49.62
191.98
151.64
65.90
74.45
96.84
92.09
95.37
157.41
Net Current Assets
644.77
439.85
792.03
738.86
627.36
539.96
480.08
-96.67
-176.37
-29.11
Total Assets
1,393.70
1,133.26
1,792.80
1,746.88
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-25.47
-163.12
194.62
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
PBT
34.59
195.17
113.17
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
Adjustment
-40.31
124.76
132.78
225.66
179.35
176.02
186.26
103.64
167.95
186.30
Changes in Working Capital
-19.76
-483.05
-51.33
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
Cash after chg. in Working capital
-25.47
-163.12
194.62
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-109.62
-104.32
-13.37
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
Net Fixed Assets
-644.27
1,330.46
-12.32
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
Net Investments
-102.98
-80.82
25.56
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
Others
637.63
-1,353.96
-26.61
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
Cash from Financing Activity
69.20
680.71
-185.66
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
Net Cash Inflow / Outflow
-65.89
413.28
-4.41
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
Opening Cash & Equivalents
493.93
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
Closing Cash & Equivalent
427.46
431.93
18.20
25.77
11.61
10.58
29.97
9.45
16.13
21.78

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
159.86
157.64
84.25
68.33
66.35
70.21
73.01
65.58
58.08
56.78
ROA
19.83%
28.79%
2.70%
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
ROE
24.68%
58.97%
10.61%
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
ROCE
24.24%
55.13%
13.25%
7.88%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
Fixed Asset Turnover
2.00
1.93
0.92
0.80
0.67
0.57
0.56
0.56
0.51
0.48
Receivable days
105.66
95.44
144.51
154.46
168.41
174.12
182.19
181.25
185.94
206.44
Inventory Days
39.47
63.55
130.51
140.01
145.99
153.65
152.15
156.48
178.26
190.95
Payable days
129.43
82.21
105.77
106.89
110.78
68.85
63.73
60.79
64.19
12.73
Cash Conversion Cycle
15.71
76.78
169.25
187.58
203.62
258.91
270.60
276.94
300.00
384.67
Total Debt/Equity
0.03
0.01
1.71
2.33
2.56
2.48
3.21
4.38
4.77
6.25
Interest Cover
89.31
12.38
1.94
1.13
1.18
0.81
1.54
2.02
0.39
0.22

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Ind-Swift Laboratories signs MoU with Him Infratech
    29th Jul 2026, 09:17 AM

    The estimated contract cost towards construction of the warehouse facility is around Rs 40 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.